Featured Press Releases

Translational Vision Science and Technology Journal Publishes RadiusXR

Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial

Galmed releases Phase 3 Aramchol results in Hepatology.

Galmed releases Phase 3 Aramchol results in Hepatology.

  • 26 Sep 2024

Galmed Pharmaceuticals Ltd. a clinical-stage biopharmaceutical company for liver, metabolic and...

TOOsonix Partners with MikronMed to Introduce Innovative Dermatological Therapy in the Nordic Region

TOOsonix Partners with MikronMed to Introduce Innovative Dermatological Therapy in the Nordic Region

Neurocrine Biosciences begins Phase 1 trial on NBI-1065890, a second-gen VMAT2 inhibitor, in healthy adults

Neurocrine Biosciences begins Phase 1 trial on NBI-1065890, a second-gen VMAT2 inhibitor, in healthy adults

To Advance Pharmacogenomics in Healthcare, Gene by Gene and myDNA Are Partnering with the University of Glasgow

To Advance Pharmacogenomics in Healthcare, Gene by Gene and myDNA Are Partnering with the University of Glasgow's Living Laboratory

Zifo Executive: Biopharma Faces AI Anxiety and Tech Obsolescence

Zifo Executive: Biopharma Faces AI Anxiety and Tech Obsolescence

CollPlant Expands Its rhCollagen 3D Bioprinting Portfolio Through the Launch of Ready-to-Print BioFlex

CollPlant Expands Its rhCollagen 3D Bioprinting Portfolio Through the Launch of Ready-to-Print BioFlex

  • CollPlant
  • 24 Feb 2026
With timsOmni™ Mass Spectrometry, Bruker Advances Functional Proteomics 2.0 for Deeper Insights into Disease Biology

With timsOmni™ Mass Spectrometry, Bruker Advances Functional Proteomics 2.0 for Deeper Insights into Disease Biology

  • Bruker Corporation
  • 24 Feb 2026
SECuRE trial update: Another participant with negative PSMA PET and undetectable PSA

SECuRE trial update: Another participant with negative PSMA PET and undetectable PSA

  • Clarity Pharmaceuticals
  • 23 Feb 2026
PureTech Secures U.S. and EU Orphan Designations for Deupirfenidone (LYT-100) in IPF

PureTech Secures U.S. and EU Orphan Designations for Deupirfenidone (LYT-100) in IPF

  • PureTech Health plc
  • 20 Feb 2026
ENFLONSIA™ (clesrovimab) shows positive new results in infants and children under 2 at increased risk of severe RSV disease across two seasons, Merck reports

ENFLONSIA™ (clesrovimab) shows positive new results in infants and children under 2 at increased risk of severe RSV disease across two seasons, Merck reports

  • Merck & Co., Inc.
  • 19 Feb 2026
Gantry-less upright proton therapy for lung cancer re-irradiation shows first-ever prospective clinical results, announced by P-Cure

Gantry-less upright proton therapy for lung cancer re-irradiation shows first-ever prospective clinical results, announced by P-Cure

  • P-Cure
  • 17 Feb 2026
Drug Discovery 2024
The Digital Pharma Advances Conference 2026

Most Popular
February   2026
M T W T F S S
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.